ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
18.49
-0.46 (-2.43%)
At close: Mar 31, 2025, 4:00 PM
17.71
-0.78 (-4.22%)
Pre-market: Apr 1, 2025, 4:22 AM EDT

ArriVent BioPharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
629898---
Enterprise Value
410615---
Last Close Price
18.4926.64---
PB Ratio
2.423.48---
P/TBV Ratio
3.483.48---
Debt / Equity Ratio
0.000.000.000.00-
Quick Ratio
12.7012.7013.0019.6020.64
Current Ratio
13.1413.1413.7621.8523.63
Return on Equity (ROE)
-39.36%-39.36%-42.57%-34.22%-
Return on Assets (ROA)
-26.91%-26.91%-26.95%-20.42%-
Return on Capital (ROIC)
-28.79%-28.79%-28.58%-21.38%-
Earnings Yield
-12.80%-8.97%---
Buyback Yield / Dilution
-1369.88%-1369.88%-67.64%-79.57%-
Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q